Radiofrequency Ablation (RFA) / Microwave Ablation (MWA)
Treatment for Liver Cancer Due To Nash
Effectiveness
80%
Safety Score
60%
Clinical Trials
300
Participants
20K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
60
DangerousModerateSafe
Treatment Details
Time to Effect
immediate
Treatment Duration
single session, may be repeated
Evidence Quality
HIGHNumber Needed to Treat (NNT)
2(Treat 2 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
30(Treat 30 patients to see 1 additional serious adverse event)
Confidence Score
88%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$500
Monitoring:$5,000
Side Effect Mgmt:$2,000
Total Annual:$22,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$30,000/QALY
QALYs Gained
3
Outcome-Based Costs
Cost per Responder
$25,000
Comparison vs Surgical Resection
Cost Difference
$-10,000/year
Less expensive
QALY Difference
+0.50 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Radiofrequency Ablation (RFA) / Microwave Ablation (MWA) Outcomes
for Liver Cancer Due To Nash
Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+90%
Common Side Effects
Pain
+35%
Fever
+20%
Liver abscess/infection
+3%
Bleeding/hemorrhage
+3%
Adjacent organ injury
+3%
Sources:
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov